These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10744479)

  • 1. Linezolid, critical characteristics.
    Hamel JC; Stapert D; Moerman JK; Ford CW
    Infection; 2000; 28(1):60-4. PubMed ID: 10744479
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
    Chien JW; Kucia ML; Salata RA
    Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid.
    D'Andrea S; Zheng ZB; Denbleyker K; Fung-Tomc JC; Yang H; Clark J; Taylor D; Bronson J
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2834-9. PubMed ID: 15911264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
    Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.
    Dresser LD; Rybak MJ
    Pharmacotherapy; 1998; 18(3):456-62. PubMed ID: 9620097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Other antimicrobials (linezolid, quinupristin/dalfopristin)].
    Yamaguchi K; Ohno A
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():756-61. PubMed ID: 12722312
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
    Ross JE; Fritsche TR; Sader HS; Jones RN
    Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients.
    Wilson AP; Cepeda JA; Hayman S; Whitehouse T; Singer M; Bellingan G
    J Antimicrob Chemother; 2006 Aug; 58(2):470-3. PubMed ID: 16735420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxazolidinone structure-activity relationships leading to linezolid.
    Barbachyn MR; Ford CW
    Angew Chem Int Ed Engl; 2003 May; 42(18):2010-23. PubMed ID: 12746812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2000 Jun; 14(2):463-74. PubMed ID: 10829266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
    Lohray BB; Lohray VB; Srivastava BK; Kapadnis PB; Pandya P
    Bioorg Med Chem; 2004 Sep; 12(17):4557-64. PubMed ID: 15358283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid, new antibiotic studied for MRSA, available for compassionate use.
    Anderson S
    AIDS Treat News; 1997 Oct; (No 281):7. PubMed ID: 11364794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.
    Anastasiou DM; Thorne GM; Luperchio SA; Alder JD
    Int J Antimicrob Agents; 2006 Nov; 28(5):385-8. PubMed ID: 17046205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
    Jankowski A; Stefanik W
    Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
    Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EUCAST Technical Note on linezolid.
    European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
    Clin Microbiol Infect; 2006 Dec; 12(12):1243-5. PubMed ID: 17121637
    [No Abstract]   [Full Text] [Related]  

  • 18. Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring.
    Tucker JA; Allwine DA; Grega KC; Barbachyn MR; Klock JL; Adamski JL; Brickner SJ; Hutchinson DK; Ford CW; Zurenko GE; Conradi RA; Burton PS; Jensen RM
    J Med Chem; 1998 Sep; 41(19):3727-35. PubMed ID: 9733498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
    Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
    J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of a series of alpha-substituted acetylpiperazinyl oxazolidinones.
    Wang XJ; Du GJ; Zhao SQ; Yan M; Gu LQ
    Chem Biol Drug Des; 2009 Sep; 74(3):276-81. PubMed ID: 19703029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.